Outgoing State Epidemiologist Criticizes Swedish Public Health Agency
Magnus Gisslén criticizes the Public Health Agency of Sweden for compromising scientific integrity and leadership expertise.
Key Points
- • Gisslén claims FHM prioritized external relationships over scientific research.
- • He criticizes the removal of group A streptococcus guidelines, which he helped develop.
- • Gisslén describes FHM's leadership as weak and calls for fundamental reforms.
- • He questions Minister Forssmed's awareness of FHM's reduced infection control competence.
Magnus Gisslén, the outgoing state epidemiologist of Sweden, has publicly criticized the Public Health Agency of Sweden (FHM) for its handling of health guidelines and leadership decisions. In a video published on August 21, 2025, Gisslén asserts that FHM has compromised its scientific integrity by prioritizing relationships with external stakeholders over sound medical evidence.
Gisslén specifically highlights the agency's recent retraction of recommendations regarding the management of group A streptococcus, a decision he argues was fundamentally misguided. "These guidelines were scientifically sound and aimed at reducing the spread of infections," he stated, expressing his dismay at the agency’s decision to withdraw them. He suggests that tensions with other health entities like the Medical Products Agency and the Strama network, which focuses on antibiotic resistance, influenced FHM's actions.
Furthermore, Gisslén critiques FHM's leadership, describing it as weak and lacking in necessary medical expertise. He calls for essential reforms, arguing that without significant changes, the agency's ability to effectively manage infection control will remain compromised. Gisslén also questions whether the responsible health minister, Jakob Forssmed, is fully aware of these deficiencies impacting FHM's capabilities.
This criticism has led Aftonbladet to reach out for comments from both FHM and Minister Forssmed regarding Gisslén's assertions, but no responses have yet been disclosed. The implications of Gisslén's statements point towards a need for urgent discussions about the integrity and effectiveness of Sweden's public health leadership in combating ongoing health challenges.